Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
In this podcast episode, listen to expert faculty perspectives on ART safety and tolerability in special populations, including pregnant people and transgender individuals.
Decera Clinical Education Infectious Disease Podcast · Jill Blumenthal MD, William R. Short MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Jill Blumenthal, MD, MAS, and William R. Short, MD, MPH, AAHIVS, address key considerations when evaluating ART safety and tolerability in pregnant people, those trying to conceive, and transgender individuals, such as:
- Approaching patients trying to conceive on nonpreferred ART regimens (eg, 2-drug regimens like LA CAB and RPV)
- Optimizing the use of the Antiretroviral Pregnancy Registry
- Addressing unique barriers to ARV adherence in transgender individuals with HIV (eg, drug formulation considerations for ARV medications and gender-affirming hormone therapy, sperm banking or egg harvesting, drug coverage considerations)
Faculty:
Jill Blumenthal, MD, MAS
Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California
William R. Short, MD, MPH, AAHIVS
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Link to full program:
http://bit.ly/3PM3nYe
Link to downloadable slides:
http://bit.ly/3WgYycz
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.